On November 10, 2011, Friends of Cancer Research (Friends) and the Engelberg Center for Healthcare Reform at Brookings co-hosted the fourth-annual Conference on Clinical Cancer Research, with the support of The American Society of Clinical Oncology (ASCO), and Susan G. Komen for the Cure. Each year, this conference brings together experts in cancer drug development from academic and clinical research, industry, federal…
On November 17, 2015, the eighth-annual Conference on Clinical Cancer Research was convened by Friends of Cancer Research and the Center for Health Policy at the Brookings Institution with the support of Susan G. Komen for the Cure. Each year, this conference brings together a diverse group of experts in cancer drug development from academic…
For the past five years, Prevision Policy has hosted a high-level conference focused on FDA and CMS policy issues. This year, Friends joined as co-hosts for the 2015 Biopharma Congress. The event previewed key issues for biopharma coming up in 2016 and had an audience comprised of regulators, industry, patient advocacy groups and congressional staff, as…
Each year, Friends of Cancer Research (Friends) and the Engelberg Center for Health Care Reform at Brookings convene the Conference on Clinical Cancer Research. This annual conference is the culmination of year spent in collaborative meetings and working groups, writing pre-conference reports and developing patient-driven solutions to the most pressing issues in cancer care. The conference…
Overview Each year, Friends of Cancer Research (Friends) and the Engelberg Center for Health Care Reform at Brookings convene the Conference on Clinical Cancer Research to address critical issues in the development of new drugs. This annual conference brings together leaders from federal health and regulatory agencies, academic research centers, patient advocacy organizations and the private sector to propose…
Documents: Panel One – Adaptive Clinical Trials Designs for Simultaneous Testing of Matched Diagnostics and Therapeutics Panel Two – Identification and Elucidation of the Biology of Adverse Events: The Challenges of Safety Assessment and Translational Medicine Panel Three – Integrating Pain Metrics into Oncologic Clinical and Regulatory Decision‐Making Panel Four: Using Patient‐Initiated Study Participation in…
